U.S. FDA classifies Aurobindo Pharma arm Eugia’s formulation plant as OAI

Aurobindo Pharma's Eugia facility in Hyderabad receives U.S. FDA's "official action indicated" classification, signaling regulatory concerns.

Raccontata dathehindu.com